The Potential Antidepressant Effect of Adenosine Triphosphate and Cerebrolysin on Reserpine Induced Depression in Male Rats.

Abstract

Background: Depression is a heterogeneous disorder that affects a person's mood, physical health and behavior. The present study aimed to investigate the potential antidepressant effect of adenosine triphosphate and cerebrolysin on reserpine induced depression in male rats through their effects on the levels of monoamine neurotransmitters and behavioral changes induced by reserpine. Material and methods: This study was conducted on 50 adult male rats divided into five groups: the first is the control group (C); the second depressed group received reserpine only. The third, fourth and fifth groups included depressed rats treated orally with citalopram as classical drug, ATP and cerebrolysin, respectively. Behavioral test, forced swim test, as well as brain neurotransmitters levels such as (MDA, 8OHdG, 5HT, DA, DOPAC, HVA, ATP and Na + -K + ATPase) measured in brain tissue. Some biochemical parameters such as ALT, AST, TSH, T 4 and testosterone were carried out in the serum. Results: Data showed that reserpine induced depressive-like behavior in the forced swim test. Additionally, reserpine produced a significant increase in the level of MAD, 8OHdG, DOPAC, HVA, T 4 , ALT and AST and significant decreased in 5-HT, DA, TSH, Testosterone, ATP and Na + -K + ATPase as compared with control group. In contrast, cerebrolysin and ATP improve the behavioral parameters, decrease oxidative markers and increase neuronal function, liver function, and thyroid function and enhance testosterone level after 21 days of treatment in comparing with reserpine group and nearly to control group. Conclusion: Cerebrolysin has pronounced effect than ATP, citalopram and ameliorate reserpine induced depression rats model.

The Fibromyalgia Pain Experience: A Scoping Review of the Preclinical Evidence for Replication and Treatment of the Affective and Cognitive Pain Dimensions

“…All identified studies in this review utilizing FST produced indications of depression-like behavior in animals as a result of the model . However, several studies utilized FST as a sole measure of affect [38][39][40][41][42][43][44][45][46][47][48]. While FST is understood to evaluate behavioral despair, which may be related to concepts of learned helplessness [71], these should not be considered unconditionally when employed as a lone measure of affective function.…”

“…Antidepressants:[37,42,43,47,49,54,56,59,61,62,66,78,80,81] Parkinson's DA agonist:[64,78] Anticonvulsants:[55,58,61,[68][69][70]72,76,81] Neurorecovery/neuroprotective:[47,50,62] Organics:[38,44,49,52,58,60,61,63,66,[68][69][70][74][75][76] Environment/Diet/Exercise:[53,56,72,83] Alternative Measures:[22,41,42,84] Other:…”

Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson’s disease induced by reserpine

“…The neurotrophic effects of cerebrolysin are mediated by its ability to prevent excitotoxicity, free radical formation, and inflammatory responses (Nasrolahi et al 2018 ; Moghazy et al 2019 ; El-Marasy et al 2021 ). The beneficial pharmacological actions underlying its clinical efficacy include enhancement of synaptic regeneration (Rockenstein et al 2003 ), promotion of neuronal survival (Safarova et al 2002 ) and augmentation of progenitor cell migration and neurogenesis (Zhang et al 2010 ; Abdel-Salam et al 2014 ).…”